Marksans Pharma advanced 2.61% to Rs 208.15 after the company's wholly owned subsidiary in the UK, Relonchem, has received marketing authorization for Baclofen Tablets from the UK Medicines and ...

Marksans Pharma Ltd shares recorded gains on Tuesday, following a significant regulatory approval obtained by its UK-based subsidiary, Relonchem Ltd. Relonchem Ltd has secured Marketing ...